Results 151 to 160 of about 58,375 (292)

Human Meningiomas Reveal No Evidence of Neuroendocrine Differentiation

APMIS, Volume 134, Issue 3, March 2026.
ABSTRACT Meningiomas are heterogeneous tumors and studies suggest that meningiomas might be part of MEN1 syndrome. The tumors express somatostatin receptors (SSTRs) comparable to that seen in neuroendocrine neoplasms. We aimed to explore neuroendocrine differentiation in meningiomas by investigating the following neuroendocrine markers: neural cell ...
Sofie Eline Tollefsen, Anders Hagen Jarmund, Ole Solheim, Ida Kaalhus Nordahl, Thi My Linh Hoang, Anette H. Skjervold, Patricia Mjønes, Sverre Helge Torp   +7 more
wiley   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, Volume 56, Issue 3, Page 465-468, March 2026.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

In Vivo Radionuclide Generators for Diagnostics and Therapy [PDF]

, 2016
Patricia E. Edem, Jesper Fonslet, Andreas Kjær, Matthias M. Herth, Gregory Severin   +4 more
openalex   +1 more source

Follow‐up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi‐ENETS Center of Excellence Study

Journal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Typical carcinoids (TC) are neuroendocrine malignancies of the lung with low risk of recurrence and a favorable prognosis. It is unclear whether lymph node status and tumor size affect the recurrence risk. Following radical surgery, current guidelines recommend comprehensive follow‐up including regular computed tomography (CT) imaging.
Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, Peter Jepsen, Ulrich Knigge, Seppo W. Langer, René Horsleben Petersen, Mikkel Andreassen, Gitte Dam   +8 more
wiley   +1 more source

177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites

, 2017
Pradeep Thapa, Rahul V. Parghane, Sandip Basu   +2 more
openalex   +1 more source

Detection of alpha radionuclides in air from patients during Ra-223 alpha radionuclide therapy [PDF]

, 2018
Seiichi Yamamoto, Katsuhiko Kato, Naotoshi Fujita, Masato Yamashita, Takuya Nishimoto, Hiroshi Kameyama, Shinji Abe   +6 more
openalex   +1 more source

Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis? [PDF]

, 2021
Anna Felis‐Giemza, Anna Apanel-Kotarska, Marek Chojnowski, Marzena Olesińska   +3 more
openalex   +1 more source

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor [PDF]

, 2017
Stefan Asbach, Fabienne Schluermann, Juri Ruf, Christoph Bode, Corinna N. Lang   +4 more
openalex   +1 more source

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy [PDF]

, 2022
Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck, Anne Schumann, Minh Nguyen, Eberhard Schneider, Jan Ungewiss, Matthias Paschke, Christian Haase, Jan L. von Hacht, Tanya T. Kwan, Kevin Lin, Jan Lenore, Thomas C. Harding, Jim Xiao, Andrew D. Simmons, Ajay-Mohan Mohan, Nicola Beindorff, Ulrich Reineke, Christiane Smerling, Frank Osterkamp   +20 more
openalex   +1 more source

Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy [PDF]

Journal of Mazandaran University of Medical Sciences
Receptor-targeted radionuclide therapy (RTRT) combines the power of particle-emitting radionuclides with the receptor-targeting capabilities of biomolecules, including antibodies and peptides.
Solmaz Mojarad-Jabali, Sajjad Molavipordanjani   +1 more
doaj